- Exchange: Tokyo
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for CanBas Co Ltd (4575)
| Open: | 2,360 | Day's Range: | 2,232 - 2,610 | Volume: | 174,200 |
|---|---|---|---|---|---|
| Previous Close: | 2,278 | 52wk Range: | 365 - 3,820 | 1-Yr Rtn: | +407.49% |
Key Statistics for 4575
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. TPX | - |
| Earnings Per Share (ttm) | -262.5300 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M JPY) | 8,585.33 |
| Shares Outstanding (M) | 3.62 |
| 30 Day Average Volume | 597,637 |
| Price/Book (mrq) | 12.9129 |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/09/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 4575
Company Profile & Key Executives for 4575
CanBas Company Ltd. is a biopharmaceutical company that develops anti-cancer drugs with fewer side effects. The Company's core technologies include drugs that target the G2 checkpoint and a screening system to find selective abrogators of the G2 checkpoint.
| Takumi KawabePresident | Makoto KatozumiDirector/CFO |
| Kazuyoshi SakamotoDirector |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
4575 News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page